STOCK TITAN

Ekso Bionics (EKSO) Stock News

EKSO Nasdaq

Welcome to our dedicated page for Ekso Bionics news (Ticker: EKSO), a resource for investors and traders seeking the latest updates and insights on Ekso Bionics stock.

Ekso Bionics Holdings Inc. news has covered its exoskeleton technology business for medical and industrial applications, including robotic systems designed to support mobility, strength, endurance, and rehabilitation. Company updates include financial results, product and distribution activity, sales trends for Enterprise Health devices and Ekso Indego Personal devices, and rehabilitation offerings such as MediTouch’s BalanceTutor system and eksoUniversity continuing education courses.

Recurring corporate developments also include material agreements, shareholder voting matters, capital-structure disclosures, governance actions, and the completed formation of ChronoScale through a strategic combination involving EKSO Bionics.

Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.65%
Tags
none
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.49%
Tags
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.01%
Tags
conferences earnings
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.12%
Tags
none
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
13.38%
Tags
conferences
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.84%
Tags
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.94%
Tags
conferences earnings
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.48%
Tags
-
Rhea-AI Summary

Ekso Bionics Holdings (Nasdaq: EKSO) will announce its financial and business results for Q1 2023 on April 27, 2023. The release will take place after the close of trading, followed by a conference call at 1:30 PM PT / 4:30 PM ET to discuss the results and recent developments. A live webcast will be available on the Company’s website, providing investors with real-time insights. This call presents an opportunity for stakeholders to engage with management regarding the company’s performance in the exoskeleton technology sector, which serves both medical and industrial markets. The replay of the call will also be accessible for one month post-event.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.59%
Tags
conferences earnings
Rhea-AI Summary

Ekso Bionics (Nasdaq: EKSO) has announced a significant collaboration with SoldierStrong, a non-profit focused on improving Veterans' lives through technology. SoldierStrong will donate an Ekso Indego Therapy device to the Spinal Cord Injury Unit at Augusta's Charlie Norwood VA Medical Center. This donation marks the 30th exoskeleton provided by SoldierStrong over the last decade, reaffirming their commitment to Veterans. The device is designed for individuals with spinal injuries and stroke, enabling them to stand and walk. A donation ceremony is scheduled for April 26, 2023, featuring a demonstration of the device, further emphasizing its clinical benefits. This partnership aims to deliver critical rehabilitation support, enhancing mobility for Veterans.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.23%
Tags
none

FAQ

What is the current stock price of Ekso Bionics (EKSO)?

The current stock price of Ekso Bionics (EKSO) is $11.8 as of May 5, 2026.

What is the market cap of Ekso Bionics (EKSO)?

The market cap of Ekso Bionics (EKSO) is approximately 42.0M.